Campto 100mg

Campto 100mg contains Irinotecan hydrochloride, an anti-cancer medication used primarily for the treatment of advanced colorectal cancer, either as a monotherapy or in combination with other chemotherapy agents. It works by inhibiting the enzyme topoisomerase I, which is involved in DNA replication, thus preventing cancer cells from multiplying and promoting their destruction.

• Irinotecan is classified as a topoisomerase inhibitor, making it effective against fast-growing cancer cells. It is typically administered via intravenous infusion under medical supervision in a hospital or clinical setting.

Patients receiving Campto 100mg may experience side effects such as nausea, vomiting, diarrhea, and lowered white blood cell counts, which can increase the risk of infections. Therefore, regular monitoring by healthcare providers is essential to manage these effects and adjust doses if necessary. This medication should be used under strict medical guidance due to its potent nature and potential toxicity.